Utah Medical Products (NASDAQ:UTMD - Get Free Report) posted its earnings results on Tuesday. The medical instruments supplier reported $0.92 EPS for the quarter, Zacks reports. Utah Medical Products had a net margin of 33.92% and a return on equity of 11.07%. The firm had revenue of $9.71 million during the quarter.
Utah Medical Products Trading Up 0.9 %
Utah Medical Products stock traded up $0.46 during mid-day trading on Friday, hitting $52.66. The company had a trading volume of 12,185 shares, compared to its average volume of 20,112. Utah Medical Products has a 12 month low of $51.26 and a 12 month high of $77.33. The stock's 50 day moving average price is $55.55 and its two-hundred day moving average price is $60.44. The company has a market capitalization of $172.83 million, a PE ratio of 13.33 and a beta of 0.30.
Utah Medical Products Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Thursday, April 3rd. Investors of record on Friday, March 14th were given a dividend of $0.305 per share. This represents a $1.22 dividend on an annualized basis and a yield of 2.32%. The ex-dividend date was Friday, March 14th. Utah Medical Products's dividend payout ratio (DPR) is presently 32.28%.
About Utah Medical Products
(
Get Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Featured Stories
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
